Australia markets closed

Enwei Pharmaceutical Co., Ltd. (301331.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.87-0.16 (-0.73%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
767,867
785,191
691,574
679,697
634,161
Cost of revenue
379,847
382,741
344,429
296,744
269,762
Gross profit
388,019
402,451
347,145
382,953
364,399
Operating expenses
Research development
16,306
16,816
7,517
4,325
4,842
Selling general and administrative
259,512
251,376
217,285
94,081
-7,664
Total operating expenses
317,753
310,254
265,530
262,541
238,811
Operating income or loss
70,266
92,197
81,615
120,412
125,588
Interest expense
-
11.9124
147.7375
3,670
8,790
Income before tax
77,659
101,315
81,862
119,129
124,473
Income tax expense
10,593
15,002
14,061
17,394
19,290
Income from continuing operations
67,067
86,312
67,801
101,735
105,183
Net income
67,067
86,312
67,801
101,735
98,743
Net income available to common shareholders
67,067
86,312
67,801
101,735
98,743
Basic EPS
1.29
1.23
1.19
1.93
2.00
Diluted EPS
1.29
1.23
1.19
1.93
2.00
Basic average shares
70,140
70,076
56,985
52,598
49,379
Diluted average shares
70,140
70,087
56,985
52,598
49,379